مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation].
Normal view MARC view ISBD view

[A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation]. [electronic resource]

By:
  • Kitao, Tatsuya
Contributor(s):
  • Ito, Yuma
  • Fukui, Masaki
  • Yamamoto, Megumi
  • Shoji, Yoshimichi
  • Takeda, Shigemitsu
  • Shirahase, Hiroaki
Producer: 20190422Description: 19-25 p. digitalISSN:
  • 1347-5231
Subject(s):
  • Administration, Oral
  • Alkaline Phosphatase -- blood
  • Animals
  • Bone Density -- drug effects
  • Bone Density Conservation Agents -- administration & dosage
  • Bone Remodeling -- drug effects
  • Bone and Bones -- metabolism
  • Cell Differentiation -- drug effects
  • Cells, Cultured
  • Cyclin-Dependent Kinase 8 -- antagonists & inhibitors
  • Dose-Response Relationship, Drug
  • Drug Discovery
  • Female
  • Humans
  • Molecular Targeted Therapy
  • Osteoblasts -- drug effects
  • Osteogenesis -- drug effects
  • Osteoporosis -- drug therapy
  • Rats
  • Stimulation, Chemical
Online resources:
  • Available from publisher's website
In: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan vol. 139
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 1 Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.
    by Jin, Chunyang
  • 2 Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.
    by Jin, Chunyang
  • 3 Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.
    by Jin, Chunyang
  • 4 A rapid functional assay for the human trace amine-associated receptor 1 based on the mobilization of internal calcium.
    by Navarro, Hernán A
  • 5 Structure-activity correlations for beta-phenethylamines at human trace amine receptor 1.
    by Lewin, Anita H
  • 6 Amiodarone and its putative metabolites fail to activate wild type hTAAR1.
    by Lewin, Anita H
  • 7 Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.
    by Jin, Chunyang
  • 8 Aporphinoid antagonists of 5-HT2A receptors: further evaluation of ring A substituents and the size of ring C.
    by Ponnala, Shashikanth
  • 9 Highly potent and selective phenylmorphan-based inverse agonists of the opioid delta receptor.
    by Thomas, James B
  • 10 Identifying structural features on 1,1-diphenyl-hexahydro-oxazolo[3,4-a]pyrazin-3-ones critical for Neuropeptide S antagonist activity.
    by Zhang, Yanan
  • 11 (+/-)-Nantenine analogs as antagonists at human 5-HT(2A) receptors: C1 and flexible congeners.
    by Chaudhary, Sandeep
  • 12 Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter.
    by Navarro, Hernán A
  • 13 Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.
    by Ponnala, Shashikanth
  • 14 Short-term adolescent nicotine exposure in rats elicits immediate and delayed deficits in T-lymphocyte function: critical periods, patterns of exposure, dose thresholds.
    by Navarro, Hernán A
  • 15 Corrigendum to "A selective delta opioid receptor antagonist based on a stilbene core" [Bioorg. Med. Chem. Lett. 25 (2015) 5532-5535].
    by Hartung, Alyssa M
  • 16 Palladium-catalyzed transformations of salvinorin A, a neoclerodane diterpene from Salvia divinorum.
    by Riley, Andrew P
  • 17 A selective delta opioid receptor antagonist based on a stilbene core.
    by Hartung, Alyssa M
  • 18 New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.
    by Chaudhary, Sandeep
  • 19 Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies.
    by Pecic, Stevan
  • 20 Stilbenes as κ-selective, non-nitrogenous opioid receptor antagonists.
    by Hartung, Alyssa M
Close

[A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation].

APA

Kitao T., Ito Y., Fukui M., Yamamoto M., Shoji Y., Takeda S. & Shirahase H. (20190422). [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation]. : Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Chicago

Kitao Tatsuya, Ito Yuma, Fukui Masaki, Yamamoto Megumi, Shoji Yoshimichi, Takeda Shigemitsu and Shirahase Hiroaki. 20190422. [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation]. : Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Harvard

Kitao T., Ito Y., Fukui M., Yamamoto M., Shoji Y., Takeda S. and Shirahase H. (20190422). [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation]. : Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

MLA

Kitao Tatsuya, Ito Yuma, Fukui Masaki, Yamamoto Megumi, Shoji Yoshimichi, Takeda Shigemitsu and Shirahase Hiroaki. [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation]. : Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 20190422.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site